Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: aÂ systematic review and meta-analysis

Article ID	Journal	Published Year	Pages	File Type
5659158	Gastrointestinal Endoscopy	2017	33 Pages	PDF

Abstract

Rectal indomethacin given before or after ERCP is protective against PEP in high-risk patients versus placebo; however, it is not protective in average-risk patients versus placebo.

Keywords

NSAID PEP ASGE ESGE Sphincter of Oddi dysfunction American Society for Gastrointestinal Endoscopy European Society of Gastrointestinal Endoscopy nonsteroidal anti-inflammatory drug SOD confidence interval odds ratio post-ERCP pancreatitis